Human Drugs View

Product Information
Registration Number BR-1461
Generic Name Ocrelizumab
Brand Name Ocrevus
Dosage Strength 300 mg/10 ml (30 mg/ml)
Dosage Form oncentrate for Solution for Intravenous Infusion
Classification Prescription Drug (RX)
Pharmacologic Category Selective Immunosuppresant
Packaging 15 mL-capacity Type I colorless glass vial with a 20 gray rubber stopper crimped with a 20 aluminium seal fitted with a plastic green flip-off cap x 10 mL- net content (Box of 1's)
Manufacturer F. Hoffmann-La Roche Ltd.
Country of Origin Switzerland
Trader
Importer Roche (Philippines), Inc.
Distributor
Application Type Monitored Release
Issuance Date 22 December 2023
Expiry Date 22 December 2028